Epistaxis and thrombocytopenia as major presentations of louse borne relapsing fever: Hospital-based study.

ABSTRACT:

Background

Louse-borne relapsing fever (LBRF) remains a cause of sporadic illness and occasional outbreaks in Ethiopia and other east African countries in overcrowded and unhygienic settings. In this article, we present clinical profiles and treatment outcome of patients treated as confirmed or probable cases of LBRF at Jimma Medical Center (JMC) in southwest Ethiopia.

Methods

Patients treated as confirmed or probable cases of LBRF at JMC during a period of May-July 2022 were prospectively followed during their course of hospital stay. All patients were evaluated with blood film for hemoparasites, complete blood count, and liver enzymes on hospital presentation. They were followed with daily clinical evaluation during their hospital stay.

Result

Thirty-six patients we

SUBMITTER: Abera EG 

PROVIDER: S-EPMC9803200 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature